Abstract:Background: Antenatal steroid therapy for fetal lung maturation is routinely administered to women at risk of preterm delivery. There is strong evidence to demonstrate benefit from antenatal steroids in terms of survival and respiratory disease, notably in infants delivered at or below 32 weeks' gestation. However, dosing remains unoptimized and lung benefits are highly variable. Current treatment regimens generate high-concentration, pulsatile fetal steroid exposures now associated with increased risk of childhood neurodevelopmental diseases. We hypothesized that damage-associated changes in the fetal hippocampal transcriptome would be independent of preterm lung function. Methods: Date-mated ewes carrying a single fetus at 122 ± 2dGA (term = 150dGA) were randomized into 4 groups: (i) Saline Control Group, 4×2ml maternal saline intramuscular(IM) injections at 12hr intervals (n = 11); or (ii) Dex High Group, 2×12mg maternal IM dexamethasone phosphate injections at 12hr intervals followed by 2×2ml IM saline injections at 12hr intervals (n = 12; representing a clinical regimen used in Singapore); or (iii) Dex Low Group, 4×1.5mg maternal IM dexamethasone phosphate injections 12hr intervals (n = 12); or (iv) Beta-Acetate Group, 1×0.125mg/kg maternal IM betamethasone acetate injection followed by 3×2ml IM sterile normal saline injections 12hr intervals (n = 8). Lambs were surgically delivered 48hr after first maternal injection at 122-125dGA, ventilated for 30min to establish lung function, and euthanised for necropsy and tissue collection. Results: Preterm lambs from the Dex Low and Beta-Acetate Groups had statistically and biologically significant lung function improvements (measured by gas exchange, lung compliance). Compared to the Saline Control Group, hippocampal transcriptomic data identified 879 differentially significant expressed genes (at least 1.5-fold change and FDR < 5%) in the steroid-treated groups. Pulsatile dexamethasone-only exposed groups (Dex High and Dex Low) had three common positively enriched differentially expressed pathways related in part to neurodegeneration ("Prion Disease", "Alzheimer's Disease", "Arachidonic Acid metabolism"). Adverse changes were independent of respiratory function during ventilation. Conclusions: Our data suggests that exposure to antenatal steroid therapy is an independent cause of damage- associated transcriptomic changes in the brain of preterm, fetal sheep. These data highlight an urgent need for careful reconsideration and balancing of how antenatal steroids are used, both for patient selection and dosing regimens.

Pituitary-adrenal responses to acute hypoxemia during and after maternal dexamethasone treatment in sheep

Changes in Maternal Glucose Metabolism after the Administration of Dexamethasone for Fetal Lung Development

Antenatal Dexamethasone: Effect on Ovine Placental 11β-Hydroxysteroid Dehydrogenase Type 2 Expression and Fetal Growth

Antenatal Dexamethasone: Effect on Ovine Placental 11|[bgr]|-Hydroxysteroid Dehydrogenase Type 2 Expression and Fetal Growth

An early prenatal exposure to excess glucocorticoid leads to hypertensive offspring in sheep

The effect of a chronic maternal cortisol infusion on the late-gestation fetal sheep

Hypoxaemia-Induced Catecholamine Secretion From Adrenal Chromaffin Cells Inhibits Glucose-Stimulated Hyperinsulinaemia In Fetal Sheep

Brief undernutrition in late-gestation sheep programs the hypothalamic-pituitary-adrenal axis in adult offspring

Prenatal Dexamethasone Programs Autonomic Dysregulation in Female Rats

Gestational Hypoxia Alone or Combined with Restraint Sensitizes the Hypothalamic–pituitary–adrenal Axis and Induces Anxiety-Like Behavior in Adult Male Rat Offspring

Effects of infusions of ACTH in the chronically catheterized pregnant ewe and her fetus

Programming of a Developmental Imbalance in Hypothalamic Glutamatergic/gabaergic Afferents Mediates Low Basal Activity of the Hypothalamic-Pituitary-adrenal Axis Induced by Prenatal Dexamethasone Exposure in Male Offspring Rats.

Antenatal steroids elicited neurodegenerative-associated transcriptional changes in the hippocampus of preterm fetal sheep independent of lung maturation

Repeated Maternal Dexamethasone Treatments in Late Gestation Increases 11Β-Hydroxysteroid Dehydrogenase Type 1 Expression in the Hippocampus of the Newborn Rat

Dexamethasone Induces Fetal Developmental Toxicity Through Affecting the Placental Glucocorticoid Barrier and Depressing Fetal Adrenal Function.

Effects of prenatal dexamethasone exposure on adult C57BL/6J mouse metabolism and oxidative stress

Tissue-specific responses that constrain glucose oxidation and increase lactate production with the severity of hypoxemia in fetal sheep

The effect of dexamethasone on mucosal immunity of uterine tissue during pregnancy in rat

Systematic Quantitative Analysis of Fetal Dexamethasone Exposure and Fetal Lung Maturation in Pregnant Animals: Model Informed Dexamethasone Precision Dose Study

Dysregulation of Glucocorticoid Receptor Homeostasis and Glucocorticoid-Associated Genes in Umbilical Cord Endothelial Cells of Diet-Induced Obese Pregnant Sheep

Adrenal Demedullation and Oxygen Supplementation Independently Increase Glucose-Stimulated Insulin Concentrations in Fetal Sheep with Intrauterine Growth Restriction.